Breaking News Instant updates and real-time market news.

MANH

Manhattan Associates

$74.47

-2.02 (-2.64%)

, TER

Teradyne

$59.24

-0.83 (-1.38%)

18:55
10/22/19
10/22
18:55
10/22/19
18:55

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Manhattan Associates (MANH) up 6.3%... Teradyne (TER) up 5.7%... Carlisle Companies (CSL) up 5.3%... Usana (USNA) up 3.3%... Navient (NAVI) up 1.2%... Discover Financial (DFS) up 0.6%. ALSO HIGHER: Hanger (HNGR) up 11.1% after entering S&P SmallCap600 index... Moderna (MRNA) up 4.0% after getting FDA fast track designation for mRNA-3927. DOWN AFTER EARNINGS: Resideo (REZI) down 28.2%... iRobot (IRBT) down 19.1%... Texas Instruments (TXN) down 9.8%, Intel (INTC) down 1.7%, Analog Devices (ADI) down 3.6%, Broadcom (AVGO) down 2.3%, Nvidia (NVDA) down 2.2%, Qualcomm (QCOM) down 1.8%, AMD (AMD) down 1.6% in sympathy... Hawaiian Holdings (HA) down 6.6%... Six Flags (SIX) down 5.7%... Whirlpool (WHR) down 4.7%... Boyd Gaming (BYD) down 3.7%... Chipotle (CMG) down 1.9%... Snap (SNAP) down 1.5%... Skechers (SKX) down 1.3%. ALSO LOWER: Soleno Therapeutics (SLNO) down 20.0% after equity offering... ServiceNow (NOW) down 9.2% after CEO departure to lead Nike (NKE). Movers as of 18:30ET.

MANH

Manhattan Associates

$74.47

-2.02 (-2.64%)

TER

Teradyne

$59.24

-0.83 (-1.38%)

CSL

Carlisle

$144.97

-0.27 (-0.19%)

USNA

Usana

$72.62

2.92 (4.19%)

NAVI

Navient

$12.16

0.19 (1.59%)

DFS

Discover

$81.30

0.85 (1.06%)

HNGR

Hanger

$20.50

0.39 (1.94%)

MRNA

Moderna

$15.90

0.42 (2.71%)

REZI

Resideo

$15.17

0.03 (0.20%)

IRBT

iRobot

$53.88

-1.82 (-3.27%)

TXN

Texas Instruments

$128.61

-2.32 (-1.77%)

INTC

Intel

$52.00

-0.12 (-0.23%)

ADI

Analog Devices

$110.91

-0.18 (-0.16%)

AVGO

Broadcom

$287.54

-2.03 (-0.70%)

NVDA

Nvidia

$195.52

-0.64 (-0.33%)

QCOM

Qualcomm

$78.46

-0.5 (-0.63%)

AMD

AMD

$31.51

-0.54 (-1.68%)

HA

Hawaiian Holdings

$30.14

0.67 (2.27%)

SIX

Six Flags

$51.22

-0.62 (-1.20%)

WHR

Whirlpool

$160.72

0.18 (0.11%)

BYD

Boyd Gaming

$26.17

0.24 (0.93%)

CMG

Chipotle

$831.69

-20.195 (-2.37%)

SNAP

Snap

$14.00

-0.58 (-3.98%)

SKX

Skechers

$38.03

0.55 (1.47%)

SLNO

Soleno Therapeutics

$1.50

0.03 (2.04%)

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

NKE

Nike

$95.61

-0.61 (-0.63%)

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 31

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 18

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 09

    Dec

  • 12

    Dec

  • 23

    Oct

MANH Manhattan Associates
$74.47

-2.02 (-2.64%)

08/12/19
RHCO
08/12/19
NO CHANGE
Target $92
RHCO
Buy
Manhattan Associates price target raised to $92 from $85 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Manhattan Associates to $92 and kept his Buy rating, saying he is turning more confident in the ability of the company's technology cycle to drive improved revenue growth and return to operating leverage. The analyst further notes that his recent discussions with Manhattan Associates' management have given him greater appreciation for the potential of the company's total addressable market expansion with its Manhattan Active Omni platform. Tillman adds that he is "comfortable" with his above-consensus forecasts for Manhattan Associates' 2020 earnings and revenue.
07/24/19
RHCO
07/24/19
NO CHANGE
Target $85
RHCO
Buy
Manhattan Associates price target raised to $85 from $71 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Manhattan Associates to $85 and kept his Buy rating after its beat-and-raise Q2 results, with software revenue and cloud revenue being the "biggest standouts" in the quarter. The analyst further notes that the company's remaining performance obligations, or RPO - the "key measure" of new cloud business - also performed strongly on net new additions.
04/22/19
RHCO
04/22/19
UPGRADE
Target $66
RHCO
Buy
Manhattan Associates rises after SunTrust upgrade to Buy on innovation optimism
As previously reported, SunTrust analyst Terry Tillman upgraded Manhattan Associates to Buy from Hold, telling investors in a note published prior to the open that he has become more positive on the company's innovation cycle and long-term dynamics for its cloud solutions. While he anticipates continued stabilizing and "at least in-line" trends through 2019, Tillman noted that his upgrade is not based on a call on Q1 results, which the company is scheduled to report after the close on Tuesday. In terms of specific product innovations that he is excited about, Tillman highlights innovation in the company's on-premise warehouse management system products and the portfolio of Active Omni cloud products. He increased his price target to $66 from $50 on Manhattan Associates shares, which are up 6.5% to $61.01 in early trading.
08/15/19
RSBL
08/15/19
INITIATION
Target $100
RSBL
Buy
Manhattan Associates initiated with a Buy at Rosenblatt
Rosenblatt analyst Yun Kim initiated Manhattan Associates with a Buy rating and a $100 price target, stating that his checks into the company's target markets point to strong secular demand for omni-channel solutions. He views Manhattan Associates as well positioned to maintain its leadership position in the expanding omni-channel market opportunity given that he believes it has the industry's most comprehensive omni-channel solutions, Kim said.
TER Teradyne
$59.24

-0.83 (-1.38%)

07/25/19
STFL
07/25/19
DOWNGRADE
Target $53
STFL
Hold
Teradyne downgraded to Hold from Buy at Stifel
Stifel analyst Brian Chin downgraded Teradyne to Hold from Buy while raising his price target for the shares to $53 from $52. The analyst says that following the company's Q2 results, the stock has now outstripped his sum-of-the-parts based target price. Robotics is an attractive long-term opportunity, but Teradyne's growth has now been revised down twice in the span of about six months, Chin tells investors in a research note. He believes the company's current valuation "seems to ignore the deteriorating visibility in this key growth segment." As such, Chin views Teradyne's risk/reward as less favorable at current share levels.
09/23/19
SBSH
09/23/19
UPGRADE
Target $68
SBSH
Buy
Advanced Energy upgraded to Buy from Neutral at Citi
Citi analyst Atif Malik upgraded Advanced Energy Industries (AEIS) to Buy from Neutral and raised his price target for the shares to $68 from $55. The analyst is moving to a "more offensive" Semiconductor Capital Equipment stance as he believes the memory market is showing signs of recovery and that 5G logic investments are accelerating, which adds confidence to his 2020/2021 wafer-fab equipment recovery thesis. Malik's top equipment picks remain Lam Research (LRCX) and Applied Materials (AMAT). He upgraded Advanced Energy to Buy and moved MKS Instruments (MKSI) to his favorite SMID cap pick. The analyst also likes KLA-Tencor (KLAC), Teradyne (TER) and Advanced Energy on their "5G appeal."
07/25/19
FBCO
07/25/19
NO CHANGE
Target $55
FBCO
Neutral
Teradyne price target raised to $55 from $45 at Credit Suisse
Credit Suisse analyst John Pitzer raised his price target for Teradyne to $55 from $45 following quarterly results. The analyst reiterates a Neutral rating on the shares.
10/01/19
KEYB
10/01/19
NO CHANGE
KEYB
KeyBanc makes four Semiconductor rating changes after trip to Asia
KeyBanc analyst Weston Twigg made four rating changes in the Semiconductors space after his quarterly trip to Asia revealed overall demand trends, while still weak, "are not getting worse." The analyst was encouraged to find inventories are beginning to normalize and that expectations are for normal seasonality in Q4. As a result, he upgraded Analog Devices (ADI), Microchip (MCHP), and NXP Semiconductors (NXPI) to Overweight from Sector Weight. Conversely, the China insourcing trends at Huawei and other manufacturers are accelerating faster than Twigg had expected, which results in his downgrade of Xilinx (XLNX) to Sector Weight from Overweight. The analyst also recommends building long-term positions in semi-cap and memory stocks like KLA-Tencor (KLAC), Teradyne (TER), Micron Technology (MU), MKS Instruments (MKSI), Entegris (ENTG), Applied Materials (AMAT) and Lam Research (LRCX). Lastly, Twigg says that initial demand for Apple's (AAPL) new iPhone "appears to be slightly worse than expected."
CSL Carlisle
$144.97

-0.27 (-0.19%)

07/08/19
BUCK
07/08/19
DOWNGRADE
BUCK
Neutral
Carlisle downgraded to Neutral from Buy at Buckingham
06/18/19
OPCO
06/18/19
NO CHANGE
Target $155
OPCO
Outperform
Carlisle price target raised to $155 from $150 at Oppenheimer
Oppenheimer analyst Bryan Blair raised his price target for Carlisle to $155 from $150 after attending the Western Roofing Expo and coming away "incrementally confident in solid underlying commercial roofing demand." The analyst reiterates an Outperform rating on the shares.
04/24/19
OPCO
04/24/19
NO CHANGE
Target $150
OPCO
Outperform
Carlisle price target raised to $150 from $140 at Oppenheimer
Oppenheimer analyst Bryan Blair raised his price target for Carlisle to $150 from $140 following quarterly results. Given CCM's favorable 2019-2020 setup, CIT and CFT's accelerating self-help stories, capital deployment optionality across platforms, and Carlisle's resultant earnings/cash generation potential, the analyst believes shares have further room to run. He reiterates an Outperform rating on the shares.
07/24/19
OPCO
07/24/19
NO CHANGE
Target $160
OPCO
Outperform
Carlisle price target raised to $160 from $155 at Oppenheimer
Oppenheimer analyst Bryan Blair raised his price target for Carlisle to $160 from $155 following quarterly results and as he continues to view it as well positioned for outsized EPS and free cash flow generation over 2019-2020. The analyst reiterates an Outperform rating on the shares.
USNA Usana
$72.62

2.92 (4.19%)

07/03/19
SIDC
07/03/19
DOWNGRADE
SIDC
Neutral
Usana downgraded to Neutral from Buy at Sidoti
08/22/19
JEFF
08/22/19
NO CHANGE
Target $65
JEFF
Hold
Jefferies starts Usana at Hold, says waiting on China rebound
As previously reported, Jefferies analyst Stephanie Wissink initiated Usana with a Hold rating and $65 price target. Usana's product line "is rooted in science but lacks distinctiveness," said Wissink, who also noted that China accounts for 55% of the company's sales and "the vast majority" of its growth. Given a lack of visibility into a rebound in China, she recommends staying on the sidelines.
07/03/19
STFL
07/03/19
NO CHANGE
Target $45
STFL
Sell
Stifel keeps Sell on Nu Skin after Usana cuts outlook on China
Nu Skin Enterprises (NUS) competitor Usana last night announced preliminary Q2 results with sales 17% below consensus and the company also lowered full year sales and earnings guidance 16% and 25%, respectively, at the midpoint, Stifel analyst Mark Astrachan tells investors in a research note. Usana's downside is largely due to softer than expected sales in China, which the company expects will continue throughout 2019, the analyst adds. He points out that increased promotional activity in China did not generate meaningful sales and customer growth. Astrachan says this is consistent with the risks noted in his downgrade of Nu Skin shares to Sell. The analyst is now more cautious on China and keeps a Sell rating on Nu Skin shares with a $45 price target.
08/22/19
JEFF
08/22/19
INITIATION
Target $65
JEFF
Hold
Usana initiated with a Hold at Jefferies
Jefferies analyst Stephanie Wissink initiated Usana with a Hold and $65 price target.
NAVI Navient
$12.16

0.19 (1.59%)

07/25/19
07/25/19
DOWNGRADE
Target $14.5

Neutral
Navient downgraded to Neutral on valuation at Credit Suisse
As previously reported, Credit Suisse analyst Moshe Orenbuch downgraded Navient to Neutral from Outperform, while raising his price target on the shares to $14.50 from $14. The analyst cited valuation and his expectation private loan CPRs will rise further. Additionally, based on management's approach to capital return and expense reductions, he ascribes a lower probability to the outcome in which they cut costs rapidly enough to maintain/improve efficiency over the longer-term.
07/25/19
07/25/19
DOWNGRADE
Target $15.75

Neutral
Navient downgraded to Neutral on valuation at Wedbush
As previously reported, Wedbush analyst Henry Coffey downgraded Navient to Neutral from Outperform, with a $15.75 price target. The analyst cited valuation as the shares traded to within a shade of his price target on Wednesday and closed at a price level in which expected total return associated with holding the stock is about 8%.
07/25/19
LEHM
07/25/19
NO CHANGE
Target $17
LEHM
Overweight
Navient price target raised to $17 from $14 at Barclays
Barclays analyst Mark DeVries raised his price target for Navient to $17 from $14 saying the company's Q2 results continued some of its positive momentum. In addition, Navient now expects a better private net interest margin given the current rate outlook, DeVries tells investors in a research note. He believes the stock's valuation remains attractive and keeps an Overweight rating on the name.
07/25/19
WEDB
07/25/19
DOWNGRADE
WEDB
Neutral
Navient downgraded to Neutral from Outperform at Wedbush
DFS Discover
$81.30

0.85 (1.06%)

07/24/19
NOMU
07/24/19
NO CHANGE
Target $96
NOMU
Buy
Discover price target raised to $96 from $86 at Nomura Instinet
Nomura Instinet analyst Bill Carcache raised his price target for Discover Financial Services to $96 from $86 saying he expects the stock to continue rising on the back of the company's Q2 results. The report was characterized by a combination of stronger revenues and lower provision expense, Carcache tells investors in a research note. He now has "even greater confidence" that an accommodative Federal Reserve and "healthy" consumer will enable Discover to sustain double-digit earnings growth. The analyst keeps a Buy rating on the shares.
07/08/19
DBAB
07/08/19
INITIATION
Target $87
DBAB
Hold
Discover reinstated with a Hold at Deutsche Bank
Deutsche Bank analyst Dave Rochester reinstated coverage of Discover Financial with a Hold rating and $87 price target.
06/19/19
BOFA
06/19/19
INITIATION
Target $82
BOFA
Neutral
Discover reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Jason Kupferberg reinstated coverage of Discover Financial Services with a Neutral rating and $82 price target. The analyst believes cyclical credit concerns remain a "potent overhang" on the shares. As a result, he sees limited potential for multiple expansion from current stock levels.
07/24/19
WELS
07/24/19
NO CHANGE
Target $88
WELS
Market Perform
Discover price target raised to $88 from $82 at Wells Fargo
Wells Fargo analyst Donald Fandetti raised his price target for Discover to $88 from $82 following another "strong quarter." The analyst reiterates a Market Perform rating on the shares.
HNGR Hanger
$20.50

0.39 (1.94%)

MRNA Moderna
$15.90

0.42 (2.71%)

06/20/19
PIPR
06/20/19
NO CHANGE
Target $30
PIPR
Overweight
Moderna recent weakness a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends using the recent weakness in shares of Moderna as a buying opportunity. The stock is down 19% on increased volume since the initial public offering lock-up expiry on June 5, Tenthoff tells investors in a research note. The analyst is most focused on the Phase I chikungunya antibody data in the second half of 2019, which he believes will have read-through to Moderna's growing orphan disease pipeline. He reiterates an Overweight rating on the shares with a $30 price target.
08/16/19
PIPR
08/16/19
NO CHANGE
Target $30
PIPR
Overweight
Moderna should be bought ahead of catalysts, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends buying shares of Moderna on weakness ahead of the company's R&D day on September 12. Moderna has completed enrollment of the Phase I study of cytomegalovirus vaccine mRNA-1647 with data soon, and the company could also report preliminary Phase I data on intratumoral mRNA-2754 by the end of 2019, Tenthoff tells investors in a research note. Further, the analyst is focused on the Phase I chikungunya antibody mRNA-1944 data in Q4 for read-through to Moderna's orphan disease pipeline. He sees multiple clinical data readouts through the end of the year and reiterates an Overweight rating on the shares with a $30 price target.
07/24/19
MSCO
07/24/19
NO CHANGE
MSCO
Warming could create need for up to $125B more vaccinations, says Morgan Stanley
Morgan Stanley analysts led by Matthew Harrison offered a report sizing the impact on biopharma from climate change. They conclude that warmer temperatures are likely to create more hospitable environments for disease transmission and they cite recent research that suggests 385M-725M more people than today may be exposed to infectious diseases such as dengue, Zika, chickungunya, and yellow fever by 2050. They estimate $50B-$125B of incremental vaccinations may be needed, but see the potential for that figure to be as high as $200B with branded pricing of more complicated vaccines. The companies best positioned to benefit from a rising need for infectious disease vaccines include Sanofi (SNY), GlaxoSmithKline (GSK), Moderna (MRNA), Merck (MRK), Johnson & Johnson's (JNJ) Janssen, Pfizer (PFE) and Takeda (TAK), according to Harrison and the team.
09/13/19
PIPR
09/13/19
NO CHANGE
Target $32
PIPR
Overweight
Moderna price target raised to $32 from $30 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Moderna to $32 from $30 after the company presented interim Phase I data on mRNA-1944 showing dose-dependent functional Chikingunya antibody production. These data have important read-through to Moderna's orphan disease pipeline, Tenthoff tells investors in a research note. He believes the company's pipeline is advancing and reiterates an Overweight rating on the shares.
REZI Resideo
$15.17

0.03 (0.20%)

12/06/18
BOFA
12/06/18
INITIATION
Target $28
BOFA
Buy
Resideo initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Peter Galbo initiated Residio with a Buy and $28 price target. Galbo expects management to execute on 4%+ organic sales growth driven by growth in the connected home space, a residential thermal solutions replacement cycle, and leveraging relationships in the contractor channel.
08/13/19
OPCO
08/13/19
NO CHANGE
Target $20
OPCO
Outperform
Resideo price target lowered to $20 from $30 at Oppenheimer
Oppenheimer analyst Ian Zaffino lowered his price target for Resideo to $20 from $30 as he is concerned with the company's margin profile over the next 2-3 years. The analyst believes Resideo could face a permanently lower margin profile in security, as well as increased investment spend and near-term headwinds created by its transition from high-margin, non-connected devices to lower-margin, connected devices. Zaffino has an Outperform rating on the shares.
03/12/19
IMPC
03/12/19
INITIATION
Target $24
IMPC
Outperform
Resideo initiated with an Outperform at Imperial Capital
Imperial Capital analyst Saliq Khan started Resideo Technologies with an Outperform rating and $24 price target. The company has a "significant presence" in the connected premises software solutions market with 4.7M connected customers and 2.3M security panel signals transmitted daily, Khan tells investors in a research note. The analyst expects Resideo's leading market share to grow.
03/12/19
03/12/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with an Overweight at Consumer Edge. 2. Crinetics (CRNX) initiated with an Overweight at Cantor Fitzgerald. 3. Tellurian (TELL) initiated with a Buy at BTIG. 4. Stealth Biotherapeutics (MITO) initiated with an Outperform at Evercore ISI, a Buy at Nomura Instinet, and a Hold at Jefferies. 5. Resideo (REZI) initiated with an Outperform at Imperial Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
IRBT iRobot
$53.88

-1.82 (-3.27%)

10/16/19
JPMS
10/16/19
NO CHANGE
Target $69
JPMS
Neutral
iRobot price target lowered to $69 from $83 at JPMorgan
JPMorgan analyst Mark Strouse lowered his price target for iRobot (IRBT) to $69 from $83 and keeps a Neutral rating on the shares ahead of the company's Q3 results. The analyst expects "some quarter-to-quarter noise" in the second half of 2019 related to timing of Amazon (AMZN) orders, which he notes are expected to be unseasonably tilted towards Q4 owing to tariffs. In addition, initial reviews for the competing high-end Shark RVC are mostly positive, which may lead to share loss for iRobot during the key holiday season, Strouse tells investors in a pre-earnings research note. While iRobot has sued Shark for patent infringement, the analyst does not expect a decision prior to year-end, "meaning that holiday sales may still be at risk."
10/09/19
RAJA
10/09/19
DOWNGRADE
RAJA
Underperform
Raymond James cites emergence of pricing war in iRobot downgrade
Raymond James analyst Brian Gesuale downgraded iRobot to Underperform from Market Perform, telling investors in a research note that he thinks Street models aren't reflecting the beginning of a meaningful commoditization cycle across the RVC category. As growth rates and profits decelerate and its workhorse product, the Roomba, is finally feeling "fatigue" after 17 years of service.
10/16/19
SBSH
10/16/19
NO CHANGE
SBSH
Neutral
Citi opens negative catalyst watch on iRobot, citing Shark litigation
Citi analyst Asiya Merchant opened a negative catalyst watch on iRobot after the company filed a motion for a preliminary injunction against the Shark IQ Robot, claiming that SharkNinja infringed on three patents related to its Roomba i7+. The analyst noted that when iRobot previously won an exclusion order in December 2018 to bar Hoover and bobSweep products from being imported into the U.S., iRobot saw "a significant increase" in litigation expenses, to about $4.3B per year from $0.6B in the prior year. Merchant, who believes that the new Shark litigation could drive increased operating expenses for the company over the next few quarters, keeps a Neutral rating on iRobot shares.
10/09/19
10/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Domino's Pizza (DPZ) downgraded to Hold from Buy at Argus with analyst John Staszak citing its worse than expected Q3 revenue and earnings along with its new 2-3 year outlook of global retail sales growth of 7%-10% - down from its prior 3-5 year outlook of 8%-12% growth. 2. FedEx (FDX) downgraded to Market Perform from Outperform at Bernstein. 3. Waters (WAT) downgraded to Underweight from Equal Weight at Barclays with analyst Jack Meehan saying as leading indicators of the macro environment continue to weaken, he sees risk to the outlook for Waters' Industrial sales exposure. 4. iRobot (IRBT) downgraded to Underperform from Market Perform at Raymond James with analyst Brian Gesuale saying he thinks Street models aren't reflecting the beginning of a meaningful commoditization cycle across the RVC category. 5. Lincoln Electric (LECO) downgraded to Hold from Buy at Stifel with analyst Nathan Jones saying he still sees Lincoln Electric as "one of the highest quality businesses" in his coverage universe thanks to its strong management and leading technologies, but believes that the headwinds in the company's end market will limit the upside for investors in the near term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TXN Texas Instruments
$128.61

-2.32 (-1.77%)

10/16/19
LOOP
10/16/19
NO CHANGE
Target $140
LOOP
Buy
Loop Capital sees cautious but optimistic tone from Texas Instruments earnings
Loop Capital analyst Cody Acree keeps his Buy rating and $140 price target on Texas Instruments ahead of its Q3 results next week. The analyst anticipates a "cautious but optimistic" tone from the earnings call, noting that many of its segments are starting to trend more positively. Acree adds that the end of estimate cuts is likely within sight for Texas Instruments as 2020 is shaping up to be a strong year for semiconductor demand, even though the near term is still overshadowed by the uncertainty related to U.S.-China trade relations.
10/14/19
LBOW
10/14/19
NO CHANGE
Target $84
LBOW
Buy
Longbow says Arrow shares' reaction 'surprisingly underwhelming' to good TI news
Longbow analyst Shawn Harrison called Arrow Electronics (ARW) "the clear winner" from news of of Texas Instruments' (TXN) consolidation of over $6B of distribution resales. The analyst, who noted that TI's plans to consolidate to six global distributors by the end of 2020 will leave Arrow as its sole fulfillment partner in North America, Europe, and Asia excluding Japan, thinks the stock's reaction thus far to the news "has been surprisingly underwhelming." Harrison maintains a Buy rating and $84 price target on Arrow shares.
10/04/19
LBOW
10/04/19
DOWNGRADE
LBOW
Neutral
Longbow downgrades Avnet to Neutral after TI plans end to distribution pact
Longbow analyst Shawn Harrison downgraded Avnet (AVT) to Neutral from Buy, citing uncertainty created by Texas Instruments' (TXN) decision to end its distribution relationship with the company. Avnet now finds itself in "an unenviable position of finding new significant cost cuts while already halfway through massive cost reductions," said the analyst, who estimates the gross profit impact is $150M, or greater than $1.00 per share of EPS. Harrison added that he expects TI to migrate the business to Arrow Electronics (ARW)
10/18/19
OPCO
10/18/19
NO CHANGE
Target $140
OPCO
Outperform
Texas Instruments price target raised to $140 from $130 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Texas Instruments to $140 from $130 and maintained an Outperform rating ahead of the company's earnings report on October 22. In a research note to investors, Schafer says he sees Q3 results in line with consensus and its Q4 outlook in line with the Street's view, adding that he expects comps to ease in Q4.
INTC Intel
$52.00

-0.12 (-0.23%)

10/13/19
NOMU
10/13/19
UPGRADE
Target $115
NOMU
Buy
Xilinx upgraded to Buy from Neutral at Nomura Instinet
Nomura Instinet analyst David Wong upgraded Xilinx (XLNX) to Buy from Neutral with an unchanged price target of $115. The stock closed Friday up $3.41 to $96.22. Many risks remain for U.S. semiconductor companies, including uncertainties related to U.S./China trade issues and U.S. action against Chinese companies such as Huawei, Wong tells investors in a research note. However, Xilinx's stock price and estimates have adjusted to reflect these risks, adds the analyst. He points out that the company is growing even with Huawei constraints. Xilinx has also gained meaningful share from Intel's (INTC) Altera in recent quarters, contends Wong.
10/21/19
MSCO
10/21/19
NO CHANGE
Target $32
MSCO
Equal Weight
AMD likely to gain share in every segment next year, says Morgan Stanley
Morgan Stanley analyst Joseph Moore said he believes AMD (AMD) has "put itself in a remarkable position" of being poised to likely gain share in every segment next year by competing successfully with both Intel (INTC) and Nvidia (NVDA) while spending a fraction of the R&D those two spend. However, he keeps an Equal Weight rating on AMD shares, stating that his 2020 EPS estimate of $1.07 gives the company "quite a bit of credit for share gains" and the $1.50 in 2020 EPS that some investors are convinced about "is possible, but certainly not a given." Moore, who sees AMD's biggest gains in the "enthusiast desktop," servers for the largest scale cloud service providers, and data center graphics, raised his price target on the stock to $32 from $30.
10/21/19
BOFA
10/21/19
NO CHANGE
BOFA
BofA says Intel faces 'achievable' bar, AMD's higher but 'could get close'
BofA Merrill Lynch analyst Vivek Arya offered his Q3 preview for Intel (INTC) and AMD (AMD), maintaining Buy ratings on both stocks ahead of their upcoming earnings reports due on Oct. 24 and 29, respectively. Intel, whose stock has underperformed the PHLX Semiconductor Sector Index (SOX) year-to-date, faces a lower bar given persistent concerns about competition, shortages and gross margin pressure. These concerns are well known, though, and demand stability in PCs and a recovery in cloud capex could help the company deliver against the "muted bar," contends Arya. Meanwhile, expectations are "steeper" for AMD, but he thinks Q4 sales guidance of at least $2B would be viewed as "good enough" as long as AMD shows gross margin leverage, the analyst tells investors.
10/18/19
LOOP
10/18/19
NO CHANGE
Target $50
LOOP
Hold
Intel data center growth to be eroded by AMD's new technology, says Loop Capital
Loop Capital analyst Cody Acree is keeping his Hold rating and $50 price target on Intel (INTC) ahead of its Q3 results next week. The analyst believes that the company will likely deliver in-line earnings and may even lift its FY19 revenue guidance again after a modest raise last quarter thanks to the strong back-to-school season sales of PCs/notebooks/tablets. Longer term however, Acree contends that Intel's market share may be challenged by AMD's (AMD) new server processors, noting that the latter's new architecture and manufacturing leadership will see a period of share gains eroding Intel's data center business growth.
ADI Analog Devices
$110.91

-0.18 (-0.16%)

10/01/19
KEYB
10/01/19
UPGRADE
Target $130
KEYB
Overweight
Analog Devices upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst John Vinh upgraded Analog Devices to Overweight from Sector Weight with a price target of $130.
10/01/19
MSCO
10/01/19
NO CHANGE
Target $115
MSCO
Overweight
NXP becoming key supplier of EV battery management systems, says Morgan Stanley
Morgan Stanley analyst Craig Hettenbach said his checks suggest that NXP Semiconductors (NXPI) is beginning to win business in battery management systems for electric vehicles against incumbents Analog Devices (ADI) and Maxim Integrated (MXIM), which he sees as a key development. BMS could add 200 basis points to the company's growth rate in autos and evidence of success in this area and other new growth drivers like Ultra-wide band and crossover MCUs should "translate directly into multiple expansion" for NXP shares, said Hettenbach. He keeps an Overweight rating and $115 price target on the stock.
10/22/19
DAIW
10/22/19
INITIATION
Target $121
DAIW
Outperform
Analog Devices initiated with an Outperform at Daiwa
Daiwa analyst Louis Miscioscia initiated coverage of Analog Devices with an Outperform rating and $121 price target.
AVGO Broadcom
$287.54

-2.03 (-0.70%)

10/01/19
KEYB
10/01/19
NO CHANGE
KEYB
iPhone 11 Pro/Max demand in line, iPhone 11 sell-through disappoints, says KeyBanc
KeyBanc analyst John Vinh says his initial round of carrier surveys for the Apple (AAPL) iPhone 11/Pro cycle indicates soft demand for the new lineup, especially the iPhone 11. While Apple's initial ramp was split evenly between 11 and Pro, the Pro/Max series demand is apparently better than iPhone 11 despite the price cut, he adds. Overall, the analyst notes that sell-through is tracking close to last year's iPhone XS/XR cycle, while somewhat worse than store expectations. Meanwhile, inventory appears to be lean for iPhone 11 Pro/Max as most stores ran out of stock soon after launch, whereas iPhone 11 inventory stood at one-plus days, he contends. Vinh's favorite Apple supply chain name is Broadcom (AVGO).
10/02/19
OTRG
10/02/19
NO CHANGE
OTRG
Broadcom largest RF dollar content vendor for new iPhones, says OTR Global
OTR Global said its review of available teardowns for Apple's (AAPL) new iPhones confirms that Broadcom (AVGO) was "again" the largest RF dollar content vendor and has gained share in device SKUs from Qorvo (QRVO).
10/10/19
LBOW
10/10/19
UPGRADE
Target $260
LBOW
Buy
Longbow upgrades Apple to Buy on better than forecast demand for new iPhones
As previously reported, Longbow analyst Shawn Harrison upgraded Apple to Buy from Neutral with a $260 price target. His contacts, who previously gave him initial conservative forecasts for up to a 10% year-over-year decline in iPhone production in the calendar third quarter, now see flat production in the period of Apple's fiscal fourth quarter, Harrison tells investors. He estimate the iPhone 11 comprises approximately 50% of new model production and his contacts now see fiscal Q1 year-over-year growth in iPhone shipments of potentially 10% or more, Harrison stated. He also calls out Apple suppliers Skyworks (SWKS), Qorvo (QRVO) and Broadcom (AVGO) as those he covers that are best positioned to see upside based on better than expected iPhone production.
09/16/19
ARGS
09/16/19
NO CHANGE
Target $350
ARGS
Buy
Broadcom attractively valued at 'significant discount', says Argus
Argus analyst Jim Kelleher kept his Buy rating and $350 price target on Broadcom after its Q3 results, saying that while the quarter topped expectations, the company guided cautiously for Q4 and the stock dipped. The analyst believes however that Broadcom's strong cash flow outlook remains intact, and it is now "attractively valued" at a "significant discount" relative to its recent valuations. Kelleher states that investors may have hoped for higher guidance given the improving enterprise demand, but contends that the reaffirmed FY19 outlook suggests the management expects the upcoming smartphone season to be "okay".
NVDA Nvidia
$195.52

-0.64 (-0.33%)

10/15/19
BOFA
10/15/19
NO CHANGE
Target $250
BOFA
Buy
Nvidia price target raised to $250 from $225 at BofA/Merrill
BofA Merrill Lynch analyst Vivek Arya raised his price target on Nvidia shares to $250 from $225 as he believes the company's data center growth will soon benefit from "the next-big AI landmark," namely natural language processing, or "conversational AI." The ability to accurately listen, understand, speak and contextualize human speech needs compute requirements 100 times that of today's dominant image/video classifier AI machines, said Arya, who sees Nvidia being "in prime position" to benefit from this shift given its portfolio of hardware and software and its developer ecosystem. Arya keeps a Buy rating on Nvidia, which he continues to identify as his top large-cap pick.
10/09/19
PIPR
10/09/19
NO CHANGE
Target $200
PIPR
Overweight
Nvidia's two biggest growth drivers are back, says Piper Jaffray
Piper Jaffray analyst Harsh Kumar believes Nvidia's (NVDA) two biggest growth drivers, namely gaming and data center, are back. Following a round of channel checks, the analyst says Nvidia is one of the best positioned semiconductor companies from a "company-specific catalyst perspective." Gaming, which represents around half of the company's revenue, appears to have settled following the GPU inventory correction, and the segment is setup for a seasonally strong second half of 2019, Kumar tells investors in a research note. In addition, the analyst is convinced Nvidia's data center business appears to have stabilized, and he sees growth in the segment moving forward. Further, Kumar thinks the Mellanox (MLNX) acquisition is on track to close by the end of calendar 2019. Lastly, based on Piper's teen survey results, the analyst believes video game interest remains high among U.S. teens. He keeps an Overweight rating on Nvidia with a $200 price target. The stock closed Tuesday down $7.10 to $177.23.
10/22/19
WELS
10/22/19
NO CHANGE
Target $220
WELS
Outperform
Nvidia price target raised to $220 from $200 at Wells Fargo
Wells Fargo analyst Aaron Rakers raised his price target for Nvidia to $220 from $220, citing its co-founder and CEO Jensen Huang positive keynote presentation at MWC Los Angeles, platform strategy that is continuing to resonate, and an expectation of a return to growth in the company's data center segment. The analyst reiterates an Outperform rating on the shares.
QCOM Qualcomm
$78.46

-0.5 (-0.63%)

09/17/19
ATLE
09/17/19
NO CHANGE
ATLE
Skyworks mentioned cautiously at Arete Research
Arete believes Qualcomm (QCOM) will replace Skyworks (SWKS) at Samsung, contacts tell The Fly.
08/21/19
MSCO
08/21/19
NO CHANGE
Target $89
MSCO
Overweight
Qualcomm, LG pact validates view FTC ruling 'irrelevant,' says Morgan Stanley
Morgan Stanley analyst James Faucette said Qualcomm's new five year agreement with LG validates his previously expressed view that Judge Koh's ruling in the FTC case is "largely irrelevant" to Qualcomm's ability to collect royalties and to their underlying economics. If either party felt like it had substantial position to gain from the 9th Circuit's eventual ruling, he does not see it as likely that an agreement would have been reached now, added Faucette, who keeps an Overweight rating and $89 price target on Qualcomm shares.
10/09/19
ADAM
10/09/19
NO CHANGE
Target $87
ADAM
Buy
Qualcomm near-term softness expected ahead of 5G ramp, says Canaccord
Canaccord analyst T. Michael Walkley said iPhone strength combined with soft global Android smartphone demand and ongoing China smartphone weak trends, will result in weak near-term results for Qualcomm. This is consistent with company guidance but the analyst remains positive long-term as he believes the company is well positioned to benefit from the transition to 5G. Walkley reiterated his Buy rating and $87 price target on Qualcomm shares.
08/26/19
MZHO
08/26/19
NO CHANGE
Target $68
MZHO
Neutral
Qualcomm scores legal victory with appeal, says Mizuho
Qualcomm on Friday scored a victory in its Ninth Circuit Court appeal, with the court granting the company a partial stay of the FTC's motion pending appeal, Mizuho analyst Vijay Rakesh tells investors in a research note. The analyst believes the partial stay is a near-term positive since Qualcomm does not have to renegotiate license and patent deals while the appeal is in process. However, near-term China uncertainty has increased with President Trump raising tariffs for September 1, adds Rakesh. He keeps a Neutral rating on shares of Qualcomm with a $68 price target.
AMD AMD
$31.51

-0.54 (-1.68%)

09/30/19
SUSQ
09/30/19
NO CHANGE
SUSQ
China macro improves as tech independence accelerates, says Susquehanna
Susquehanna analyst Christopher Rolland said his trip to Asia revealed an improving macro environment as china accelerates its plans for technological independence. The analyst noted CPU shortages at both Intel (INTC) and AMD (AMD) as well as expectations for an (AAPL) Apple iPhones sales peak expected in October.
HA Hawaiian Holdings
$30.14

0.67 (2.27%)

10/21/19
BUCK
10/21/19
NO CHANGE
Target $88
BUCK
Buy
Alaska Air price target raised to $88 from $78 at Buckingham
Buckingham analyst Daniel McKenzie raised his price target for Alaska Air (ALK) to $88 from $78 and lowered his price target for American Airlines (AAL) to $42 from $43. He maintained Buy ratings on both airline names ahead of Q3 earnings this week. In a research note to investors, McKenzie says the industry is set to deliver Q3 pre-tax profits of $5.8B, up 16.5% year-over-year, primarily on top line revenue growth. The analyst believes Alaska Air, American Airlines, Hawaiian Holdings (HA) and JetBlue (JBLU) are most likely to outperform on revenue and EPS execution, while he thinks Spirit Airlines (SAVE) is the most likely to disappoint.
08/20/19
STFL
08/20/19
DOWNGRADE
Target $20
STFL
Sell
Hawaiian Holdings downgraded to Sell from Buy at Stifel
Stifel analyst Joesph DeNardi double downgraded Hawaiian Holdings (HA) to Sell from Buy and cut its price target to $20 from $30 citing 2020 earnings risk. DeNardi sees downside to 2020 consensus earnings estimates due to declining PRASM results starting in 2020 and Southwest's (LUV) announced additional capacity to Hawaii, which will likely lead to further market share losses.
07/29/19
MACQ
07/29/19
DOWNGRADE
MACQ
Neutral
Macquarie warns about pricing pressure among airlines from Southwest competition
Macquarie analyst Susan Donofrio downgraded American Airlines (AAL), Spirit Airlines (SAVE), Hawaiian Holdings (HA), and Alaska Air (ALK) to Neutral from Outperform as part of a broader industry note, saying the competitive environment for these airlines should become "choppy" in the fall of 2019 and in 2020 as Southwest (LUV) attempts to win back market share. The analyst believes that the latter's sizable domestic scope should lead to "unit revenue softness" within the overall pricing structure, through she maintains an Outperform rating on United Airlines (UAL), Delta (DAL) and Allegiant (ALGT) given their ongoing revenue initiatives and minimal overlap with Southwest.
08/21/19
08/21/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cree (CREE) downgraded to Market Perform from Outperform at JMP Securities with analyst Joseph Osha saying the company has forecasted soft business conditions to persist into the quarter. 2. Hawaiian Holdings (HA) double downgraded to Sell from Buy at Stifel with analyst Joesph DeNardi citing 2020 earnings risk. 3. Chimera (CIM) downgraded to Neutral from Outperform at Credit Suisse with analyst Douglas Harter citing valuation. 4. Synlogic (SYBX) downgraded to Sell from Buy at Citi and to Perform from Outperform at Oppenheimer. 5. Jazz Pharmaceuticals (JAZZ) downgraded to Neutral from Overweight at Piper Jaffray with analyst David Amsellem citing his survey of 30 current prescribers of Xyrem in order to gauge whether there will be physician appetite for using recently approved Wakix, either in replacement or in combination. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SIX Six Flags
$51.22

-0.62 (-1.20%)

10/04/19
10/04/19
NO CHANGE

Cedar Fair told Wells Fargo analyst it is not looking to be sold
10/04/19
WELS
10/04/19
NO CHANGE
WELS
Outperform
Six Flags an aggressive buy as Cedar Fun deal very unlikely, says Wells Fargo
While no specific comment was made regarding the Reuters article of Six Flags Entertainment (SIX) making a bid, Cedar Fair (FUN) management stated that the company is not looking to be sold, Wells Fargo analyst Timothy Conder told investors last night in a research note. Cedar Fair management conducted scheduled one-on-one meetings earlier in the week and has scheduled meetings next week, but did not participate in a conference yesterday based on counsel's advice, adds the analyst. The company has previously chosen not to convert to a C-Corp as this would involve either trigging a substantial tax bill for unitholders, or the tax bill being borne by the new C-Corp in the form of higher go forward tax rates, "neither of which is acceptable," says Conder. The analyst believes this same dilemma would face Six Flags in the event of an acquisition. For his part, Conder has yet to find any type of multiple stock class structures that would work and avoid the ability to defer a transactional tax bill to either unitholders or the surviving C-Corp. In addition, Six Flags launched a repricing of its $798M term loan due 2026 on September 30, Conder points out. It would be "strange that the company would do this ahead of a major acquisition bid," he says. As such, the analyst reiterates his view that a Six Flags acquisition of Cedar Fair is "highly unlikely." He also believes the recent pullback in Six Flags shares is "overdone and unwarranted." Candor would be an "aggressive" of Six Flags ahead of what he expects will be "solid" Q3 results from both companies. And if the recent buyout talk subsides, the analyst sees only a "modest" $2-$3 per share give back in Cedar Fun. He keeps an Outperform rating on both stocks.
10/04/19
KEYB
10/04/19
NO CHANGE
KEYB
Overweight
Keybanc says bid near $85 per share would be hard for Cedar Fair not to consider
After Reuters reported that Cedar Fair (FUN) has rejected a $70 stock-and-cash offer made by Six Flags (SIX) as too low, Keybanc analyst Brett Andress said his conversations with Cedar Fair lead him to conclude that the company is not for sale, "but everything does have a price." He thinks a bid near $85 per share would be "hard for Cedar Fair unitholders to turn down (or at least seriously consider)," Andress tells investors. While a theoretical $85 bid might be "doable," it would require a massive amount of equity "and this $85 scenario is still a far stretch," said the analyst, who admits that he "also thought SIX's initial idea to even approach FUN was a stretch." Andress has Overweight ratings on both Six Flags and Cedar Fair shares.
10/04/19
JEFF
10/04/19
NO CHANGE
Target $57
JEFF
Hold
Jefferies doesn't see Six Flags paying over $68 per share for Cedar Fair
The potential acquisition of Cedar Fair (FUN) by Six Flags Entertainment (SIX) brings "modestly positive" outcomes from a financial perspective, but more profound benefit strategically, Jefferies analyst David Katz tells investors in a research note. The potential merger with, if true, is more transformative than Six Flags' prior deals, adds the analyst. His broad assumptions include a $68 per share offer for Cedar Fair based on a neutral enterprise value to EBITDA multiple to Six Flags. Cedar Fun closed Thursday up $1.33 to $61.05. Said differently, the analyst assumes Six Flags would not pay higher than its current valuation of 10.3 times estimated 2020 EBITDA. Katz keeps a Hold rating on Six Flags with a $57 price target.
WHR Whirlpool
$160.72

0.18 (0.11%)

10/15/19
BUCK
10/15/19
NO CHANGE
Target $150
BUCK
Neutral
Buckingham backs Neutral on Whirlpool following AHAM data
Buckingham analyst Megan McGrath maintained a Neutral rating and $150 price target on Whirlpool shares after the Association of Home Appliance Manufacturers, or AHAM, released "strong" U.S. appliance shipment data for the month of September. McGrath noted that AHAM 6 shipment growth in the month fell "slightly," a deterioration from the high single digit growth reported last month, and as a result is keeping her third quarter estimates unchanged at this time. The analyst noted that her revenue growth estimate for Whirlpool's North America business in Q3 is 2.5%, adding that if the company was able to gain share or maintain mid-single digit pricing growth, there could be "some upside" to her estimates. McGrath said her Neutral rating is, in part, based on "slow demand" in the U.S. market and concerns over pricing if demand continues to be lackluster, as well as a slowing end market in Europe.
09/26/19
09/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Outperform from Market Perform at Wells Fargo analyst Timothy Willi saying the company's fundamentals remain strong while investor sentiment is "overly negative and close to inflecting." 2. Whirlpool (WHR) upgraded to Overweight from Neutral at JPMorgan with analyst Michael Rehaut saying he expects U.S. industry shipments to be more stable year-over-year through the end of 2019 and show "modest" growth in 2020. 3. Boston Beer (SAM) upgraded to Outperform from Market Perform at BMO Capital with analyst Amit Sharma saying Truly is "primed to capture" strong consumer demand and higher distribution/shelf space for hard seltzer. 4. AbbVie (ABBV) upgraded to Buy from Neutral at Citi with analyst Andrew Baum saying he believes AbbVie will "extract significant shareholder value" from Allergan's (AGN) franchises given its "strong commercial focus and patient/physician centricity." 5. Hologic (HOLX) upgraded to Buy from Neutral at BofA/Merrill with analyst Ivy Ma saying she sees the company being on "steadier footing with organic growth upside in FY20" thanks to its tuck-in acquisitions. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/19
JPMS
09/26/19
UPGRADE
Target $172
JPMS
Overweight
Whirlpool upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Rehaut upgraded Whirlpool to Overweight from Neutral and raised his price target for the shares to $172 from $155.
09/26/19
JPMS
09/26/19
UPGRADE
Target $172
JPMS
Overweight
JPMorgan upgrades Whirlpool to Overweight, boosts price target to $172
JPMorgan analyst Michael Rehaut upgraded Whirlpool (WHR) to Overweight from Neutral and raised his price target for the shares to $172 from $155. The analyst expects U.S. industry shipments to be more stable year-over-year through the end of 2019 and show "modest" growth in 2020. Further, he thinks point to steel prices will remain "at bay" and that Whirlpool's European operations will "finally" turn a small profit in the second half of 2019. In addition, Rehaut views the stock's valuation as inexpensive. The analyst this morning also downgraded Beacon Roofing Supply (BECN) to Underweight from Neutral. His top picks in the Building Products sector remain Stanley Black & Decker (SWK) and Fortune Brands (FBHS).
BYD Boyd Gaming
$26.17

0.24 (0.93%)

07/31/19
TLSY
07/31/19
UPGRADE
Target $36
TLSY
Outperform
Boyd Gaming upgraded to Outperform from Market Perform at Telsey Advisory
Telsey Advisory analyst Brian McGill upgraded Boyd Gaming to Outperform from Market Perform and raised his price target for the shares to $36 from $31.
06/14/19
WOLF
06/14/19
INITIATION
Target $37
WOLF
Outperform
Boyd Gaming initiated with an Outperform at Wolfe Research
Wolfe Research analyst Jared Shojaian started Boyd Gaming with an Outperform rating and $37 price target.
07/24/19
SUSQ
07/24/19
INITIATION
SUSQ
Neutral
Boyd Gaming initiated with a Neutral at Susquehanna
Susquehanna analyst Joseph Stauff initiated Boyd Gaming with a Neutral rating and $28 price target, calling it the "most understated credible operator," but he prefers to wait for a better valuation.
06/11/19
JPMS
06/11/19
NO CHANGE
Target $34
JPMS
Overweight
Boyd Gaming risk/reward 'compelling' at current levels, says JPMorgan
JPMorgan analyst Joseph Greff says Boyd Gaming offers a "compelling" risk/reward profile at current share levels. He lowered his price target for the stock to $34 from $40 and keeps an Overweight rating on the name. Boyd can be a direct and indirect beneficiary of continued gaming industry consolidation, Greff tells investors in a research note. Further, he points out that regional gaming stocks have historically outperformed in the early summer months.
CMG Chipotle
$831.69

-20.195 (-2.37%)

10/18/19
10/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Neutral from Sell at Citi with analyst Adam Spielman saying he now expects "less bad" cigarette volumes next year. 2. Snap (SNAP) upgraded to Buy from Neutral at BofA/Merrill with analyst Justin Post saying the stock has sold off despite "solid" industry and advertising spend channel checks. 3. Chipotle (CMG) upgraded to Neutral from Underperform at BofA/Merrill with analyst Gregory Francort saying he expects the company to generate better comps and margins over the near term given its "strong" sales momentum and normalizing avocado prices, even though he is "struggling" with the valuation on the stock. 4. Republic Services (RSG) upgraded to Buy from Neutral at BofA/Merrill with analyst Michael Feniger calling the stock "a more balanced way" to gain exposure to the theme of higher disposal pricing than peer Waste Management (WM), which he downgraded this morning. 5. Waste Connections (WCN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Sean Eastman saying he expects Waste Connections to report an in-line Q3, and sees 2019 guidance remaining intact. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/21/19
BTIG
10/21/19
NO CHANGE
Target $890
BTIG
Buy
Chipotle price target raised to $890 from $845 at BTIG
BTIG analyst Peter Saleh raised his price target on Chipotle to $890 and kept his Buy rating, saying that investors should not be "blinded" by the valuation on the stock as the company remains in the "middle innings" of its turnaround thanks to its efforts on digital ordering, menu innovation, and marketing. The analyst maintains that annual earnings of $25 per share are "achievable" as sales recover, leading to the expansion of restaurant and operating margins.
10/18/19
RHCO
10/18/19
NO CHANGE
Target $920
RHCO
Buy
Chipotle price target raised to $920 from $900 at SunTrust
SunTrust analyst Jake Bartlett raised his price target on Chipotle to $920 and kept his Buy rating ahead of its Q3 earnings as part of his broader research note previewing the quarter for the Restaurants group. The analyst expects the company to beat on comps and issue a "strong" same-store-sales guidance for Q4, adding that its outlook for accelerating developments in FY20 should lead to upside in the stock price. Bartlett further notes that in addition to Chipotle's prior same-store-sales drivers, including delivery, digital order/pickup, and rewards programs, the national launch of Carne Asada has "significantly" increased its check mix while driving more traffic.
10/21/19
LOOP
10/21/19
NO CHANGE
Target $950
LOOP
Buy
Chipotle price target raised to $950 from $860 at Loop Capital
Loop Capital analyst Lynne Collier raised her price target on Chipotle to $950 and kept her Buy rating ahead of its earnings tomorrow. The analyst expects the company's national launch of Carne Asada to be a "hit" and is also raising her Q3 SSS forecast to 9.5% from 7.9% while boosting her Q3 earnings view by 16c to $3.20. Collier contends that Chipotle's momentum can continue thanks to its growth in digital ordering, improving operations, and menu innovation.
SNAP Snap
$14.00

-0.58 (-3.98%)

10/18/19
10/18/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Investors Real Estate (IRET) initiated with an Outperform at Raymond James. 2. Pinterest (PINS) and Snap (SNAP) initiated with a Neutral at MKM Partners. 3. Intellicheck (IDN) initiated with a Buy at B. Riley FBR. 4. Welbilt (WBT) initiated with a Market Perform at BMO Capital. 5. Endava (DAVA) initiated with a Buy at Needham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/21/19
FBCO
10/21/19
NO CHANGE
Target $21
FBCO
Outperform
Snap ads forecast raised for Q3 at Credit Suisse
Credit Suisse analyst Stephen Ju has raised his Snap Ads forecast for Q3 by $10M based on positive feedback from advertisers. The analyst believes Snap has come full circle to begin delivering on the investment thesis at the time of its public offering and he is looking forward to a sustained period of lower gyrations to its users along with revenue growth driven by primarily ad impressions. Ju reiterates an Outperform rating for Snap, while raising his price target on the shares to $21 from $20 given potential for better-than-expected user growth with a revamped Android app released in more geographies, potential for better-than-expected ad revenue on ramping ad load growth, and as Snap is a scarce asset that offers advertisers access to a coveted younger demographic.
10/21/19
LITP
10/21/19
INITIATION
Target $20
LITP
Buy
Snap initiated with a Buy at LightShed Partners
LightShed Partners analyst Rich Greenfield initiated coverage of Snap with a Buy rating and $20 price target. In June, when formerly with BTIG, Greenfield had raised his price target on Snap to $20 and kept his Buy rating on the stock.
10/21/19
CLVD
10/21/19
NO CHANGE
CLVD
Snap advertiser outlook seen getting more bullish, says Cleveland Research
Cleveland Research analyst Chandler Converse said his channel checks indicate that advertisers' outlook on Snap (SNAP) appears more bullish in recent feedback, adding that Q3 "sounds stronger than expected" as the company seems to be executing better. Converse also said in a note on social advertising checks that Pinterest (PINS) partners point to growing advertisers and strong pipelines of net new clients. Converse does not have ratings on Snap or Pinterest shares.
SKX Skechers
$38.03

0.55 (1.47%)

07/19/19
SUSQ
07/19/19
NO CHANGE
Target $42
SUSQ
Positive
Skechers price target raised to $42 from $37 at Susquehanna
Susquehanna analyst Sam Poser raised his price target on Skechers to $42 from $37 following strong Q2 results. The analyst noted its strong Q3 guidance showing it is making good progress in controlling costs, managing inventory, and driving more profitability through a willingness to better manage sales growth. Poser reiterated his Positive rating on Skechers shares.
07/19/19
WEDB
07/19/19
UPGRADE
WEDB
Outperform
Skechers upgraded to Outperform from Neutral at Wedbush
07/19/19
07/19/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Post Holdings (POST) upgraded to Overweight from Neutral at Piper Jaffray with analyst Michael Lavery saying he expects "good" organic sales growth of 2%-3%) and still consider Post's portfolio attractive for cash generation. 2. Philip Morris (PM) upgraded to Overweight from Equal Weight at Barclays with analyst Gaurav Jain saying the company's new fiscal 2019 revenue growth guidance ex-currency of 6% is towards the higher end in staples. 3. KBR (KBR) upgraded to Outperform from Market Perform at Cowen with analyst Gautam Khanna citing abating overhangs, strong sales, an extreme sum-of-the-parts discount, and improving balance sheet flexibility. Khanna raised his price target to $31 from $23 on KBR shares. 4. WW (WW) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citing the improving sentiment toward the company's brands, taglines, and programs garnered from the Davidson Brand Sentiment Analysis as the company has already posted improved recruitment trends. 5. Skechers (SKX) upgraded to Outperform from Neutral at Wedbush. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/22/19
ARGS
07/22/19
NO CHANGE
ARGS
Hold
Skechers' next several quarters to be weighed by DTC investment, says Argus
Argus analyst John Staszak is keeping his Hold rating on Skechers in spite of its better than expected Q2 results, saying he sees the company's increased investment in direct-to-consumer business and its international operations to weigh on its margins over the next few quarters. The analyst is also worried about the impact of the China trade dispute and the softer economy in Europe, keeping his FY19 and FY20 EPS estimates unchanged at $1.90 and $2.20.
SLNO Soleno Therapeutics
$1.50

0.03 (2.04%)

07/08/19
LDLW
07/08/19
INITIATION
Target $10
LDLW
Buy
Soleno Therapeutics initiated with a Buy at Laidlaw
Laidlaw analyst Francois Brisebois initiated Soleno Therapeutics with a Buy rating and $10 price target, citing the view that lead product Diazoxide Choline Controlled Release tablets to treat Prader-Willi Syndrome could fill a significant unmet medical need. The analyst also believes the FDA allowing Soleno to treat patients as young as four years old "is a testament to DCCR's impressive safety profile," Brisebois stated in his initiation note.
NOW ServiceNow
$228.26

-12.315 (-5.12%)

10/16/19
MSCO
10/16/19
DOWNGRADE
Target $267
MSCO
Equal Weight
Morgan Stanley downgrades ServiceNow to Equal Weight as risks seen rising
As previously reported, Morgan Stanley analyst Keith Weiss downgraded ServiceNow to Equal Weight from Overweight with an unchanged $267 price target. Weiss said the company remains "best-in-class," but it faces increasing near-term risks, including a CFO transition that may result in more cautious initial guidance for FY20 than most investors expect; tougher subscription billings comparisons in the second half of the year; and high expectations with the stock up more than 50% year-to-date, Weiss tells investors. He also noted that the firm's recent CIO survey highlighted the increasingly uncertain macro environment, particularly in Europe, which is another concern for ServiceNow.
10/16/19
10/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Adobe (ADBE) downgraded to Neutral from Buy at Citi with analyst Walter Pritchard saying he believes the stock's risk/reward is "more balanced" with the company's fiscal 2020 guidance "likely to be less conservative." 2. Acuity Brands (AYI) downgraded to Neutral from Outperform at Baird and to Perform from Outperform at Oppenheimer. 3. Costco (COST) downgraded to Neutral from Buy at Northcoast with analyst Chuck Cerankosky citing valuation. 4. ServiceNow (NOW) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Keith Weiss saying the company remains "best-in-class," but it faces increasing near-term risks, including a CFO transition that may result in more cautious initial guidance for FY20 than most investors expect; tougher subscription billings comparisons in the second half of the year; and high expectations with the stock up more than 50% year-to-date. 5. Extraction Oil & Gas (XOG) downgraded to Equal Weight from Overweight at Stephens with analyst Gail Nicholson citing the Q3 production miss, and increased cautiousness around oil. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/18/19
RBCM
10/18/19
NO CHANGE
Target $320
RBCM
Top Pick
Strong Q3 results, new CFO announcement to support ServiceNow, says RBC Capital
RBC Capital analyst Alex Zukin is keeping his Top Pick rating and $320 price target on ServiceNow ahead of its Q3 results next week. The analyst notes that the his quarter-end checks and the discussions at the recent customer/partner event suggest that the company's performance in the quarter was strong, with better than expected growth in North America. Zukin adds that the decline of 3.4% this week and 14% since the release of Q2 results driven by concerns about EMEA weakness, sales attrition, and management changes sets up potential near term upside catalysts for ServiceNow with the likely announcement of a new CFO and the expected strong Q3 earnings.
10/17/19
MACQ
10/17/19
NO CHANGE
Target $335
MACQ
Outperform
ServiceNow selloff yesterday a buying opportunity, says Macquarie
Macquarie analyst Sarah Hindlian recommends using the selloff yesterday in shares of ServiceNow as a buying opportunity. The analyst's channel checks suggest a "solid quarter" with North American resellers "pointing well ahead of plan." Further, a CFO appointment is in the final stages and may be announced soon "while Snowflake concerns are overblown," Hindlian tells investors in a research note. She believes investors should be building positions in ServiceNow going into its "seasonally strong" second half of the year. She reiterates an Outperform rating on the shares with a $335 price target.
NKE Nike
$95.61

-0.61 (-0.63%)

10/14/19
BOFA
10/14/19
UPGRADE
Target $98
BOFA
Neutral
Nike upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst Robert Ohmes upgraded Nike (NKE) to Neutral with a price target of $98, saying that he expects the "accelerated democratization" of the brand to offset the broader future challenges around "significant" third-party retail store closures and global stagnation in "performance" footwear/apparel. The analyst notes that while Adidas (ADDYY) is resurging as a global competitor, he sees the decline in consensus estimates for Nike as having ended and anticipates some Q1 earnings upside from the company's "less technical "Sportswear" businesses".
10/18/19
FBCO
10/18/19
NO CHANGE
Target $112
FBCO
Outperform
Nike price target raised to $112 from $105 at Credit Suisse
Credit Suisse analyst Michael Binetti raised his price target for Outperform-rated Nike to $112 from $105, saying accelerating global revenue trends and better SG&A leverage should translate to accelerating EPS upside through FY20 and into FY21. Binetti calls Nike's innovation pipeline "the strongest we've seen in years."
10/14/19
BOFA
10/14/19
UPGRADE
BOFA
Neutral
Nike upgraded to Neutral from Underperform at BofA/Merrill
10/14/19
10/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Neutral from Underperform at BofA/Merrill with analyst Robert Ohmes saying that he expects the "accelerated democratization" of the brand to offset the broader future challenges around "significant" third-party retail store closures and global stagnation in "performance" footwear/apparel. 2. Western Digital (WDC) upgraded to Buy from Hold at Loop Capital with analyst Ananda Baruah citing his findings that flash memory average selling prices are set to increase starting in the September and December quarters while also sustaining those increases in 2020, along with expectations of strong hyperscale HDD demand next year. 3. Varian Medical (VAR) upgraded to Buy from Neutral at BTIG with analyst Sean Lavin saying Varian shares have pulled back in recent weeks and now trade in line with the comp group. 4. Xilinx (XLNX) upgraded to Buy from Neutral at Nomura Instinet with analyst David Wong saying many risks remain for U.S. semiconductor companies, including uncertainties related to U.S./China trade issues and U.S. action against Chinese companies such as Huawei. 5. HP Enterprise (HPE) upgraded to In Line from Underperform at Evercore ISI with analyst Amit Daryanani saying he is incrementally more positive on cash flow resiliency, the Cray acquisition, recent data points that indicate H3C is performing better than other OEMs in China, and valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$310.82

-1.07 (-0.34%)

17:51
11/20/19
11/20
17:51
11/20/19
17:51
Periodicals
Trump expected to sign bill supporting Hong Kong protesters, Bloomberg reports »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$310.82

-1.07 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRPX

Therapix Biosciences

$1.50

-0.13 (-7.98%)

17:49
11/20/19
11/20
17:49
11/20/19
17:49
Hot Stocks
Therapix Biosciences to appeal Nasdaq delisting notice »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$117.84

4.43 (3.91%)

17:47
11/20/19
11/20
17:47
11/20/19
17:47
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

NDAQ

Nasdaq

$105.68

0.52 (0.49%)

17:39
11/20/19
11/20
17:39
11/20/19
17:39
Periodicals
Nasdaq executive Nelson Griggs sees fewer IPOs in 2020, Bloomberg says »

Nelson Griggs, executive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$57.91

-0.46 (-0.79%)

17:37
11/20/19
11/20
17:37
11/20/19
17:37
Hot Stocks
Intel acknowledges PC CPU shipment delays in letter »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

  • 23

    Jan

AAPL

Apple

$263.19

-3.13 (-1.18%)

, SPX

S&P 500

$0.00

(0.00%)

17:35
11/20/19
11/20
17:35
11/20/19
17:35
Periodicals
Trump says considering whether to exempt Apple from China tariffs, Reuters says »

U.S. President Donald…

AAPL

Apple

$263.19

-3.13 (-1.18%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$310.82

-1.07 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$216.91

-1.26 (-0.58%)

17:28
11/20/19
11/20
17:28
11/20/19
17:28
Hot Stocks
Raytheon awarded $386M Air Force contract modification »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLH

Red Lion Hotels

$3.36

0.015 (0.45%)

17:23
11/20/19
11/20
17:23
11/20/19
17:23
Syndicate
Breaking Syndicate news story on Red Lion Hotels »

Red Lion Hotels files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KZIA

Kazia Therapeutics

$7.40

4 (117.65%)

17:20
11/20/19
11/20
17:20
11/20/19
17:20
Hot Stocks
Breaking Hot Stocks news story on Kazia Therapeutics »

Kazia Therapeutics Ltd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$30.05

0.13 (0.43%)

17:14
11/20/19
11/20
17:14
11/20/19
17:14
Syndicate
Invitation Homes announces offering of 57.6M shares of common stock for holders »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVV

Universal Corporation

$50.73

-0.84 (-1.63%)

17:08
11/20/19
11/20
17:08
11/20/19
17:08
Hot Stocks
Universal Corporation to acquire FruitSmart, terms not stated »

Universal Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$28.02

0.99 (3.66%)

17:06
11/20/19
11/20
17:06
11/20/19
17:06
Hot Stocks
Breaking Hot Stocks news story on Uber »

Uber up 2.1% or 59c at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 04

    Dec

SBLK

Star Bulk Carriers

$10.04

-0.12 (-1.18%)

17:03
11/20/19
11/20
17:03
11/20/19
17:03
Earnings
Star Bulk Carriers reports Q3 EPS 18c, two estimates 17c »

Reports Q3 voyage revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

KRNY

Kearny Financial

$14.11

-0.08 (-0.56%)

17:01
11/20/19
11/20
17:01
11/20/19
17:01
Hot Stocks
Kearny Financial raises quarterly dividend to 7c from 6c per share »

Payable on December 20 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$16.00

-1.19 (-6.92%)

16:48
11/20/19
11/20
16:48
11/20/19
16:48
Hot Stocks
Breaking Hot Stocks news story on L Brands »

L Brands up 5.8% or 92c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 05

    Dec

LVMUY

LVMH

$0.00

(0.00%)

, TIF

Tiffany

$123.32

-0.16 (-0.13%)

16:47
11/20/19
11/20
16:47
11/20/19
16:47
Periodicals
LVMH, Tiffany said to be in talks, Bloomberg says »

LVMH (LVMUY) is said to…

LVMUY

LVMH

$0.00

(0.00%)

TIF

Tiffany

$123.32

-0.16 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

LB

L Brands

$16.00

-1.19 (-6.92%)

16:46
11/20/19
11/20
16:46
11/20/19
16:46
Hot Stocks
L Brands backs FY19 free cash flow forecast at ~$750M »

Cuts FY19 SSS view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 05

    Dec

UBER

Uber

$28.02

0.99 (3.66%)

16:43
11/20/19
11/20
16:43
11/20/19
16:43
Hot Stocks
Uber CEO Dara Khosrowshahi buys almost $7M in company shares »

Uber CEO Dara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 04

    Dec

AVVIY

Aviva

$0.00

(0.00%)

16:42
11/20/19
11/20
16:42
11/20/19
16:42
Downgrade
Aviva rating change  »

Aviva downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLLGY

Hella KGaA Hueck

$0.00

(0.00%)

16:42
11/20/19
11/20
16:42
11/20/19
16:42
Upgrade
Hella KGaA Hueck rating change  »

Hella GmbH upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEG

Key Energy

$0.30

0.0095 (3.32%)

16:40
11/20/19
11/20
16:40
11/20/19
16:40
Hot Stocks
Key Energy receives notice from NYSE regarding continued listing requirements »

Key Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLLGY

Hella KGaA Hueck

$0.00

(0.00%)

16:40
11/20/19
11/20
16:40
11/20/19
16:40
Upgrade
Hella KGaA Hueck rating change  »

Hella KGaA Hueck upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGHC

National General

$20.47

-0.43 (-2.06%)

16:39
11/20/19
11/20
16:39
11/20/19
16:39
Hot Stocks
National General approved to sell its Accident Health and Care Sweden unit »

National General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$126.37

15.51 (13.99%)

, LOW

Lowe's

$117.84

4.43 (3.91%)

16:38
11/20/19
11/20
16:38
11/20/19
16:38
On The Fly
Fly Intel: Wall Street's top stories for Wednesday »

Stocks were slumping a…

TGT

Target

$126.37

15.51 (13.99%)

LOW

Lowe's

$117.84

4.43 (3.91%)

GM

General Motors

$35.26

-1.13 (-3.11%)

FCAU

Fiat Chrysler

$15.00

-0.585 (-3.75%)

KNSA

Kiniksa

$8.95

1.97 (28.22%)

ALNY

Alnylam

$108.26

10.27 (10.48%)

URBN

Urban Outfitters

$24.41

-4.32 (-15.04%)

PDD

Pinduoduo

$31.37

-9.34 (-22.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 03

    Dec

  • 05

    Dec

  • 07

    Dec

  • 04

    Feb

TUWOY

Tullow Oil

$0.00

(0.00%)

16:37
11/20/19
11/20
16:37
11/20/19
16:37
Downgrade
Tullow Oil rating change  »

Tullow Oil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.